Haemophilus influenzae type b and pneumococcal conjugate vaccination coverage in children aged 2-59 months in Malawi
- PMID: 32574099
- PMCID: PMC7899636
- DOI: 10.1080/21645515.2020.1773142
Haemophilus influenzae type b and pneumococcal conjugate vaccination coverage in children aged 2-59 months in Malawi
Abstract
High vaccination coverage with Haemophilus influenzae type b (Hib) and pneumococcal conjugate vaccines is critical to addressing childhood pneumonia's high mortality. The Innovative Treatments in Pneumonia project in Lilongwe, Malawi collected Hib and pneumococcal vaccination information from children's health passports and found the majority demonstrated inadequate and inconsistent documentation. We were unable to confidently assess the impact of Hib and pneumococcal vaccination on pneumonia treatment failure in our study population. Whether it be that enrolled children did not receive age-eligible vaccines or there was poor vaccination record-keeping, we do not know. A shift to an electronic data collection system may help ensure capture of essential vaccination data and provide more accurate records of both individual and population vaccination coverage in Malawi.
Keywords: Pneumococcal vaccine; children; pneumonia; vaccination.
References
-
- United Nations Inter-agency Group for Child Mortality Estimation . Levels & trends in child mortality: report 2019, Estimates developed by the United Nations Inter-agency group for child mortality estimation. New York, NY: United Nations Fund; 2019.
-
- 2018 Assessment report of the Global Vaccine Action Plan . Strategic advisory group of experts on immunization. Geneva, Switzerland: World Health Organization; 2018.
-
- World Health Organization . Global vaccine action plan 2011–2020, 2013.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical